Plexus Ventures
Plexus
We help companies identify, evaluate, and negotiate in-licensing opportunities to expand their growth potential and geographic presence.
We are global experts in pharmaceutical divestments, working with companies to target buyers, generate competition for assets, and maximize proceeds.
We help firms identify potential product and company acquisitions, develop deal structures, and negotiate definitive agreements.
We advise companies in developing an out-licensing strategy and guide them in maximizing the value of their compounds, products, and technologies.
GLOBAL PRESENCE world

+1-310-584-7480

info@plexusventures.com
RECENT NEWS
  • August 23, 2011 Labormed Pharma Retains Plexus Ventures for Product Divestment Support
  • July 22, 2011 AstraZeneca Engages Plexus Ventures for Global Divestments
  • June 24, 2011 Plexus Ventures Successfully Concludes Product Divestment Assignment
  • June 6, 2011 Plexus Ventures to Support Reckitt Benckiser in Portfolio Divestment
PharmaTimes World News
  • May 18, 2012Giving statins to the well saves lives, research finds
  • May 18, 2012HGS adopts poison pill to thwart GSK, in talks with other firms
  • May 18, 2012FDA opens gates for generic Plavix as patent expires
  • May 18, 2012US FDA reviews new drugs faster than EMA, Health Canada, says study
  • May 17, 2012New Novartis COPD drug beats placebo over a year
Home | About | Services | Track Record | News Room | Contact | Japanese Japanese Language
  • Overview
  • Our Approach
  • Our History
  • Our Team
  • Our Offices
  • Overview
  • In-Licensing
  • Out-Licensing
  • Acquisitions
  • Divestments
  • Overview
  • Case Studies
  • Client List
  • Press Releases
  • Articles & Presentations
  • Media Inquiries